Seminars in Dialysis最新文献

Pharmacological Treatment for Dialysis-Related Muscle Cramps: A Systematic Review. 透析相关肌肉痉挛的药物治疗：系统回顾。

IF 1.4 4区医学

Seminars in Dialysis Pub Date : 2024-11-01 Epub Date: 2024-08-18 DOI: 10.1111/sdi.13223

Nidia Mantilla-Manosalva, Santiago Guadarrama, Lennis Jazmin Bedoya-Muñoz, Sara Giraldo-Moreno, Laura Cuellar-Valencia, María Fernanda Iriarte-Aristizábal, Marta Ximena León, Fernan Alejandro Mendoza-Montenegro, Juan Esteban Correa-Morales

{"title":"Pharmacological Treatment for Dialysis-Related Muscle Cramps: A Systematic Review.","authors":"Nidia Mantilla-Manosalva, Santiago Guadarrama, Lennis Jazmin Bedoya-Muñoz, Sara Giraldo-Moreno, Laura Cuellar-Valencia, María Fernanda Iriarte-Aristizábal, Marta Ximena León, Fernan Alejandro Mendoza-Montenegro, Juan Esteban Correa-Morales","doi":"10.1111/sdi.13223","DOIUrl":"10.1111/sdi.13223","url":null,"abstract":"Background: Patients with end-stage renal disease undergoing dialysis suffer from muscle cramps, a prevalent and burdensome symptom for which there is a paucity of efficient and safe treatments.Aim: What is the efficacy and safety of pharmacological interventions for the treatment of dialysis-related muscle cramps?Design: A systematic review was conducted in OVID, CINAHL, PubMed, Web of Science, and Central Cochrane databases up to August 25, 2023.Data sources: Experimental studies reporting on a pharmacological intervention for the treatment of dialysis-related muscle cramps were included. The review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis, and the studies quality was assessed with the RoB2 tool.Results: A total of 4660 studies were retrieved, and 13 articles were included. The studies reported on nine interventions: vitamin C, vitamin E, vitamin K2, vitamin B7, dextrose solutions, gabapentin, sodium chloride, creatine monohydrate, and L-carnitine. The studies testing L-carnitine and creatine monohydrate were the only ones deemed to have a low risk of bias. Side effects were reported in only two trials, consisting primarily of gastrointestinal discomfort and hyperglycemia. Vitamins C and E are the two most studied interventions that showed positive results in reducing the frequency, severity, and duration of dialysis-related muscle cramps. L-carnitine is a promising intervention that warrants further investigation.Conclusion: Our review consolidates the existing evidence, elucidating the range of treatments along with their potential benefits and limitations. Future studies should uphold high-quality standards, incorporate patient-reported outcomes, and utilize well-defined, robust samples to improve patient care.","PeriodicalId":21675,"journal":{"name":"Seminars in Dialysis","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142000640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Continuous Renal Replacement Therapy Needs Its Own Circuit Diagram. 连续性肾脏替代疗法需要自己的电路图。

IF 1.4 4区医学

Seminars in Dialysis Pub Date : 2024-11-01 Epub Date: 2024-08-21 DOI: 10.1111/sdi.13222

Xiankun Sun, Fang Wang, Ling Zhang, Zhiwen Chen

引用次数: 0

Does the Use of Gastric-Acid Suppressants Increase the Risk of Peritonitis in Patients Undergoing Peritoneal Dialysis? A Meta-Analysis. 使用胃酸抑制剂会增加腹膜透析患者患腹膜炎的风险吗？一项 Meta 分析。

IF 1.4 4区医学

Seminars in Dialysis Pub Date : 2024-11-01 Epub Date: 2024-08-25 DOI: 10.1111/sdi.13226

Lili Yao, Linfeng Ni, Xu Wu

{"title":"Does the Use of Gastric-Acid Suppressants Increase the Risk of Peritonitis in Patients Undergoing Peritoneal Dialysis? A Meta-Analysis.","authors":"Lili Yao, Linfeng Ni, Xu Wu","doi":"10.1111/sdi.13226","DOIUrl":"10.1111/sdi.13226","url":null,"abstract":"Gastric-acid suppressants (GASs) are commonly prescribed to patients undergoing peritoneal dialysis for various gastrointestinal disorders. However, long-term GAS use has been linked with the risk of enteric peritonitis in this patient population. To assess the association between the enteric peritonitis risk and GAS use in patients undergoing peritoneal dialysis for end-stage renal disease, we conducted a systematic search for relevant articles published until December 2023 in PubMed, Embase, and the Cochrane Library databases. We included 11 articles on the association between GAS use and enteric peritonitis risk in patients undergoing peritoneal dialysis. We calculated pooled odds ratios (ORs) with 95% confidence intervals (CIs) using fixed and random-effects models to obtain overall effect estimates. We also explored potential sources of heterogeneity through subgroup analyses. We qualitatively analyzed data from 11 studies (n = 1993 participants), out of which, nine studies were included in meta-analysis. The overall results revealed a significant association between the enteric peritonitis risk and the use of GASs (OR, 1.61; 95% CI, 1.26-2.05; p < 0.00001). The analysis of study design subgroups showed a significant association in retrospective cohort studies (OR, 1.70; 95% CI, 1.42-2.03; p < 0.00001) but not in case-control studies. Histamine-2 receptor antagonist (H2RA) use was significantly associated with enteric peritonitis (OR, 1.49; 95% CI, 1.05-2.11, p = 0.03), whereas proton pump inhibitor use was not (OR, 1.13; 95% CI, 0.72-1.77, p = 0.28). Our findings suggest a significant association between the development of enteric peritonitis and GAS use in patients undergoing peritoneal dialysis. However, the observed heterogeneity in study characteristics warrants caution in interpreting the results.","PeriodicalId":21675,"journal":{"name":"Seminars in Dialysis","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142056463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Vancomycin Dosing Strategy for the Treatment of Peritonitis in a Child on Automated Peritoneal Dialysis: A First Pediatric Case Report. 治疗自动腹膜透析患儿腹膜炎的万古霉素剂量策略：首例儿科病例报告。

IF 1.4 4区医学

Seminars in Dialysis Pub Date : 2024-11-01 Epub Date: 2024-08-22 DOI: 10.1111/sdi.13224

David Haefliger, Hassib Chehade, Francoise Livio, Viviane Rodrigues-Veiga, Léonore Diezi, Catia Marzolini

{"title":"Vancomycin Dosing Strategy for the Treatment of Peritonitis in a Child on Automated Peritoneal Dialysis: A First Pediatric Case Report.","authors":"David Haefliger, Hassib Chehade, Francoise Livio, Viviane Rodrigues-Veiga, Léonore Diezi, Catia Marzolini","doi":"10.1111/sdi.13224","DOIUrl":"10.1111/sdi.13224","url":null,"abstract":"Background: Bacterial peritonitis is a common complication of peritoneal dialysis. In the absence of systemic signs of infection, adult guidelines recommend treatment with intraperitoneal vancomycin either as empiric coverage of gram-positive organisms or as targeted therapy. However, there is no guidance on how to administer vancomycin in children on automated peritoneal dialysis.Case report: We report vancomycin pharmacokinetics upon intraperitoneal administration for the treatment of a Staphylococcus hominis peritonitis in an 11-year-old patient on automated nocturnal intermittent peritoneal dialysis. While the patient was hospitalized, vancomycin was administered intraperitoneally as a continuous treatment. After hospital discharge, the nocturnal peritoneal dialysis was resumed. In the absence of treatment guidelines, intraperitoneal vancomycin was initially administered empirically only during the nocturnal dialysis exchanges which led to repetitive subtherapeutic vancomycin plasma concentrations and the persistence of S. hominis in dialysate cultures. Based on studies in adults, the dosing strategy was subsequently modified to administer vancomycin at a dosage of 15 mg kg-1 in the dialysate with a 6-h dwell period prior to the nocturnal dialysis thereby allowing to reach optimal peak concentrations. The dosing interval was subsequently individualized using therapeutic drug monitoring to ensure residual vancomycin concentrations > 10 mg L-1 thereby leading to clinical and microbiological recovery.Conclusions: This case presents a dosing strategy based on a comprehensive review of the literature and highlights that a sufficient dwell period is critical when treating pediatric patients on automated peritoneal dialysis in order to allow vancomycin distribution and equilibration between the dialysate and the plasma.","PeriodicalId":21675,"journal":{"name":"Seminars in Dialysis","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142036817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Thyroid Function Trends in Dialysis: Unveiling Peritoneal and Hemodialysis Disparities. 透析中的甲状腺功能趋势：揭示腹膜透析和血液透析的差异。

IF 1.4 4区医学

Seminars in Dialysis Pub Date : 2024-11-01 Epub Date: 2024-09-07 DOI: 10.1111/sdi.13228

Jelić Pranjić Ita, Orlić Lidija, Srdoč Nemarnik Lori, Vrdoljak Margeta Tea, Šimić Jelena, Bubić Ivan

{"title":"Thyroid Function Trends in Dialysis: Unveiling Peritoneal and Hemodialysis Disparities.","authors":"Jelić Pranjić Ita, Orlić Lidija, Srdoč Nemarnik Lori, Vrdoljak Margeta Tea, Šimić Jelena, Bubić Ivan","doi":"10.1111/sdi.13228","DOIUrl":"10.1111/sdi.13228","url":null,"abstract":"Background: The interplay between peritoneal dialysis (PD), residual kidney function (RKF), and thyroid function remains poorly understood, with limited prospective studies comparing thyroid function in PD versus hemodialysis (HD) patients.Methods: This prospective single-center study assessed thyroid function in 18 PD patients over a 24-month follow-up period at the Department of Nephrology, Dialysis, and Kidney Transplantation, UHC Rijeka, Croatia. Data were compared to 24 concurrently treated HD patients.Results: Initially, some PD patients exhibited elevated TSH levels, which normalized during follow-up despite longer dialysis duration. Compared to HD patients, PD patients demonstrated significantly higher T4 concentrations at baseline and higher FT4 concentrations at 12 and 24 months. Furthermore, FT3 levels were significantly higher in PD patients at baseline and at both 12 and 24 months, with T3 levels also within the reference interval after the beginning of the study. Additionally, a positive association was observed between T4 levels and 24-h diuresis after 12 months in PD patients.Conclusion: Recognizing additional risk factors and potential impacts on RKF and cardiovascular comorbidities in dialysis patients can enhance patient care, influence dialysis modality selection, and guide ongoing patient monitoring. Thorough evaluation of thyroid function in PD and HD patients is essential for optimizing clinical outcomes and overall well-being. This study contributes to understanding the complex interplay between thyroid function, RKF, and dialysis modality, emphasizing the need for further research to inform comprehensive patient care strategies.","PeriodicalId":21675,"journal":{"name":"Seminars in Dialysis","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142146216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Tidal Versus Intermittent Peritoneal Dialysis in Chronic Peritoneal Dialysis Patients: Randomized, Open-Label, Prospective Control Study. 慢性腹膜透析患者潮汐式腹膜透析与间歇式腹膜透析：随机、开放标签、前瞻性对照研究。

IF 1.4 4区医学

Seminars in Dialysis Pub Date : 2024-11-01 Epub Date: 2024-09-04 DOI: 10.1111/sdi.13227

Jia-Wen Lai, Charles C N Wang, Pao-Hsia Chang, Che-Yi Chou

{"title":"Tidal Versus Intermittent Peritoneal Dialysis in Chronic Peritoneal Dialysis Patients: Randomized, Open-Label, Prospective Control Study.","authors":"Jia-Wen Lai, Charles C N Wang, Pao-Hsia Chang, Che-Yi Chou","doi":"10.1111/sdi.13227","DOIUrl":"10.1111/sdi.13227","url":null,"abstract":"Background: Tidal peritoneal dialysis (TPD) provides better fluid flow mechanics and is more comfortable for the patient, owing to fewer alarms and less pain during inflow and outflow. The long-term characteristics of patients with TPD were not evident. In this randomized controlled follow-up study, we aimed to explore the characteristics of patients with TPD, compared to IPD.Methods: A total of 85 patients were randomized to either IPD or 70% TPD between January 2019 and December 2020, and all patients were followed up on December 2021. The characteristics of patients between the two groups were analyzed using a t-test or chi-square as appropriate. The overall survival and technical survival were analyzed using Kaplan-Meier analysis.Results: Forty-two patients were assigned to IPD, and 43 patients were assigned to TPD. The basal characteristics of patients were not different between the two groups. In an average of 16 months of follow-up, 19 patients died, and 25 patients dropped out of peritoneal dialysis. The two groups had no difference in overall survival and technical survival. TPD was associated with high urine volume (p = 0.001), lower blood urea nitrogen (p = 0.002), lower phosphorus (p = 0.004), and fewer cycler alarms (p < 0.001). The chance of patients reporting abdominal fullness was higher in patients with TPD (p = 0.001).Conclusion: In the randomized, controlled, follow-up study, TPD may preserve residual renal function and is associated with lower urea nitrogen and phosphorus in chronic peritoneal dialysis patients. TPD is associated with fewer cycler alarms but may increase the chance of patients reporting abdominal distension.","PeriodicalId":21675,"journal":{"name":"Seminars in Dialysis","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142126624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Increase of Hepatitis B Surface Antibody Levels After Inactivated COVID-19 Vaccine in Hemodialysis Patients: An Important Single-Center Observation. 血液透析患者接种 COVID-19 灭活疫苗后乙肝表面抗体水平升高：重要的单中心观察结果

IF 1.4 4区医学

Seminars in Dialysis Pub Date : 2024-11-01 Epub Date: 2024-09-27 DOI: 10.1111/sdi.13229

Fatemeh Yaghoubi, Davood Dalil, Saeid Iranzadeh, Ali Ghahramani

{"title":"Increase of Hepatitis B Surface Antibody Levels After Inactivated COVID-19 Vaccine in Hemodialysis Patients: An Important Single-Center Observation.","authors":"Fatemeh Yaghoubi, Davood Dalil, Saeid Iranzadeh, Ali Ghahramani","doi":"10.1111/sdi.13229","DOIUrl":"10.1111/sdi.13229","url":null,"abstract":"Background: The effects of COVID-19 vaccines on immunocompromised people such as hemodialysis (HD) patients are an important topic that should be addressed. This study reports an observation of the effect of the third dose of the Sinopharm vaccine (SphV3) on the level of hepatitis B surface antibody (anti-HBs) in HD patients, and the differences between anti-HBs titers before and after SphV3 were analytically evaluated.Methods: This single-center observational study involved all HD patients presented to Shariati Hospital, Tehran, Iran, from February 2021 to March 2022. All patients received three doses of the Sinopharm vaccine over 8 months. The anti-HBs level is measured every 6 months as the routine evaluation against HBV infection for all HD patients. Three months before (anti-HBs-B3) and 3 months after (anti-HBs-A3) SphV3 were the routine times to measure the anti-HBs titer during this study.Results: Twenty-five HD patients were enrolled. Overall, the anti-HBs-A3 was significantly higher than anti-HBs-B3 (p = 0.001). The anti-HBs levels before and after SphV3 were not statistically remarkable in patients with diabetes and ischemic heart disease. The patients with a history of kidney transplant and those with a history of COVID-19 had significant differences between anti-HBs-B3 and anti-HBs-A3 (p = 0.002, p = 0.003, respectively).Conclusion: Our findings revealed that inactivated COVID-19 vaccine may be involved in the humoral immune response to hepatitis B in HD patients. It may be novel and have significant implications for the vaccination protocol for immunocompromised patients, including those undergoing HD and transplant recipients.","PeriodicalId":21675,"journal":{"name":"Seminars in Dialysis","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142353073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A Case Report of a Hemodialysis Patient With Coagulation Factor XI and Factor XII Deficiencies. 一名血液透析患者凝血因子 XI 和因子 XII 缺乏症的病例报告。

IF 1.4 4区医学

Seminars in Dialysis Pub Date : 2024-11-01 Epub Date: 2024-08-18 DOI: 10.1111/sdi.13219

Xueying Li, Yong Wang

引用次数: 0

A Rare Cause of Hypotension in Routine Hemodialysis: Secondary Adrenal Insufficiency. 常规血液透析中低血压的罕见病因：继发性肾上腺功能不全。

IF 1.4 4区医学

Seminars in Dialysis Pub Date : 2024-11-01 Epub Date: 2024-08-22 DOI: 10.1111/sdi.13225

Murat Altunok, Hüsnü Serdar Kızıltunç, Erdem Çankaya, Can Sevinç, Abdullah Uyanık

{"title":"A Rare Cause of Hypotension in Routine Hemodialysis: Secondary Adrenal Insufficiency.","authors":"Murat Altunok, Hüsnü Serdar Kızıltunç, Erdem Çankaya, Can Sevinç, Abdullah Uyanık","doi":"10.1111/sdi.13225","DOIUrl":"10.1111/sdi.13225","url":null,"abstract":"Hypotension is a common complication during hemodialysis that develops due to high ultrafiltration rate and sometimes requires intravenous fluid replacement. Intradialytic hypotension may reduce the effectiveness of dialysis and contributes to hemodialysis-related morbidity and mortality. Adrenal insufficiency is one of the causes of hypotension in the community. Our case was diagnosed with end-stage renal failure and was undergoing routine hemodialysis with a central venous catheter 3 days a week. Upon the patient's hypotension attacks during the dialysis sessions and hypoglycemia attacks in the follow-ups, the morning cortisol was 6.2 μg/dL. Adrenocorticotropic hormone was 39 pg/mL, and testosterone was 0.0442 ng/mL. Adrenocorticotropic hormone stimulation test was performed on the patient with 250 mcg tetracosactide. The patient did not show adequate cortisol response, was detected to have partial empty sella on pituitary magnetic resonance imaging, and was diagnosed with secondary adrenal insufficiency, and then the hemodialysis hypotension improved with prednisolone treatment. We present a case of adrenal insufficiency, which is a rare cause of hypotension in patients on routine hemodialysis.","PeriodicalId":21675,"journal":{"name":"Seminars in Dialysis","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142036816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Catheter Exchange With Elongation of Tunnel (CEET) Procedure-A Novel Technique for Cuff Extrusion of Tunneled Dialysis Catheter: Surgical Experience and Early Outcomes. 隧道延长导管置换术（CEET）--隧道透析导管袖带挤压的新技术：手术经验与早期疗效。

IF 1.4 4区医学

Seminars in Dialysis Pub Date : 2024-10-24 DOI: 10.1111/sdi.13230

Vineet Behera, Hemant Mehta, C S Vishwanath, J Balasubramaniam, G Shanmugraj, R Ananthakrishnan, Vivek Hande

{"title":"Catheter Exchange With Elongation of Tunnel (CEET) Procedure-A Novel Technique for Cuff Extrusion of Tunneled Dialysis Catheter: Surgical Experience and Early Outcomes.","authors":"Vineet Behera, Hemant Mehta, C S Vishwanath, J Balasubramaniam, G Shanmugraj, R Ananthakrishnan, Vivek Hande","doi":"10.1111/sdi.13230","DOIUrl":"https://doi.org/10.1111/sdi.13230","url":null,"abstract":"Background: Cuff extrusion of tunneled dialysis catheter (TDC) leads to catheter dysfunction, leading to loss of vascular access and the need for new catheter. Definitive management is to remove TDC and reinsert new catheter by new venous puncture and tunnel, which may not be possible in all cases. The study evaluated the surgical experience and early outcomes of a novel \"Catheter Exchange with Elongation of Tunnel (CEET)\" procedure for cuff extrusion.Methods: The retrospective study included all cases of hemodialysis with TDC with partial or complete cuff extrusion and excluded complete catheter dislodgement, tunnel infection, or any catheter related infection. All patients also underwent the CEET procedure under fluoroscopy guidance, and the clinical details and outcomes were analyzed.Results: Eleven cases of TDC cuff extrusion underwent the CEET procedure of which three (27.2%) had previous and four (36.4%) had partial cuff extrusion, and seven cases (63.6%) had short tunnel length, which likely predisposed to cuff extrusion. CEET procedure was successful in 10 cases (success rate 90.1%) with desired position of catheter tip and good blood flow. Study population was divided into early and late cuff extrusion (≥1 month). Short tunnel length was associated with late extrusion (p = 0.05), whereas premature removal of TDC anchor sutures was associated with early cuff extrusion (p = 0.04).Conclusion: CEET procedure is a successful alternative technique for correction of cuff extrusion of TDC with good success rate. Premature removal of anchor sutures was associated with early cuff extrusion, whereas short tunnel length was associated with late cuff extrusion.","PeriodicalId":21675,"journal":{"name":"Seminars in Dialysis","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142507138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0